Practices
Industries

14 December 2020

The Ministry of Healthcare of the Russian Federation approved the "Procedure for monitoring the safety of medical devices" (hereinafter referred to as the "Procedure"), which will come into force on January 1, 2021, and will be valid until January 1, 2027.

Lidings Experts Run Master Class in Summer Masters’ School at LMSU

27 August 2020

August 27th, 2020 Lidings Managing Partner Andrey Zelenin and Associate Julia Kuzmenko will run a special master class dedicated to Legal Advice to Life Sciences Companies: Lawyer’s Knowledge and Capabilities as a part of the two-day educational programme of the Lomonosov Moscow State University entitled Summer Masters’ School (SMS). Becoming traditional this summer students’ event is scheduled on August 27–28 and this year will run in a Zoom format.

COVID-19: Legal Watch

25 July 2020

The coronavirus outbreak (COVID-19) served as a trigger for a targeted effort to assess and manage the possible effects of it. The Russian Government continues to update the measures taken or introduce new ones, trying to act ahead of the possible adverse consequences. Our lawyers are closely monitoring the situation, watching out for the new measures introduced in relation to the coronavirus.
We offer overview of key legislative changes and recommendations for business in the current pandemic.

New explanations of the FAS Russia on certain aspects of advertising in the field of pharmaceuticals and healthcare

30 June 2020

Specification of the information about the license is not required directly in the advertising of medical activities that are subject to licensing. Verification of the presence of relevant documents is carried out at the request of the advertising distributor in accordance with article 13 of the Law on advertising. The advertiser, in turn, shall provide reports, including information about the availability of a license, mandatory certification and state registration.